STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

Abstract

The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.</p

    Similar works